483
Emily K. Curran, M.D.FDA 483 - Emily K. Curran, M.D. - June 03, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Emily K. Curran, M.D. in Cincinnati, OH, revealed significant deviations from the investigational plan and signed statement of investigator. The firm failed to properly manage investigational product dosing for two subjects in sub-studies. One subject continued treatment despite protocol-mandated holds due to adverse lab results, and another received an incorrect dose level for multiple cycles.
Open in Dashboard
ID · fce3b72d-fe35-4e8d-a140-df1eb403b411